FSHD was the first disorder to be associated with aberrant expression of DUX4. It is the third most common type of muscular dystrophy, with a worldwide prevalence of 1 in 8000 to 20,000 individuals, depending on ancestry [28]. This evidence concerns the gene DUX4 and facioscapulohumeral muscular dystrophy.